StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.34−0.05 (-13.17%)

Close on Nov 17, 2026Market cap $2.97MP/E 0.3Yield –

Evogene operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$14.03M. The highest annual figure on record is -$14.03M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.03M–
FY2024Dec 31, 2024-$18.80M–
FY2023Dec 31, 2023-$22.23M–
FY2022Dec 31, 2022-$26.94M–
FY2021Dec 31, 2021-$30.95M–
FY2020Dec 31, 2020-$24.81M–
FY2019Dec 31, 2019-$21.17M–
FY2018Dec 31, 2018-$19.99M–
FY2017Dec 31, 2017-$21.95M–
FY2016Dec 31, 2016-$21.09M–
FY2015Dec 31, 2015-$17.92M–

More Evogene figures

See a number that looks wrong?